Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The adverse effects of overdiagnosis and overtreatment observed in men with clinically insignificant prostate cancers after the introduction of prostate-specific antigen-based screening are now being observed in those with thyroid cancer, owing to the introduction of new imaging technologies. Thus, the evolving paradigm of active surveillance in prostate and thyroid cancers might be valuable in informing the development of future active surveillance protocols. The lessons learned from active surveillance and their implications include the need to minimize the use of broad, population-based screening programmes that do not incorporate patient education and the need for individualized or shared decision-making, which can decrease the extent of overtreatment. Furthermore, from the experience in patients with prostate cancer, we have learned that consensus is required regarding the optimal selection of patients for active surveillance, using more-specific evidence-based methods for stratifying patients by risk. In this Review, we describe the epidemiology, pathology and screening guidelines for the management of patients with prostate and thyroid cancers; the evidence of overdiagnosis and overtreatment; and provide overviews of existing international active surveillance protocols.

Original languageEnglish (US)
Pages (from-to)168-184
Number of pages17
JournalNature Reviews Clinical Oncology
Volume16
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Thyroid Neoplasms
Prostatic Neoplasms
Patient Education
Prostate-Specific Antigen
Patient Selection
Consensus
Decision Making
Epidemiology
Medical Overuse
Guidelines
Pathology
Technology
Population

ASJC Scopus subject areas

  • Oncology

Cite this

@article{290f634bf8094985a5e154dd26a03f38,
title = "Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned",
abstract = "The adverse effects of overdiagnosis and overtreatment observed in men with clinically insignificant prostate cancers after the introduction of prostate-specific antigen-based screening are now being observed in those with thyroid cancer, owing to the introduction of new imaging technologies. Thus, the evolving paradigm of active surveillance in prostate and thyroid cancers might be valuable in informing the development of future active surveillance protocols. The lessons learned from active surveillance and their implications include the need to minimize the use of broad, population-based screening programmes that do not incorporate patient education and the need for individualized or shared decision-making, which can decrease the extent of overtreatment. Furthermore, from the experience in patients with prostate cancer, we have learned that consensus is required regarding the optimal selection of patients for active surveillance, using more-specific evidence-based methods for stratifying patients by risk. In this Review, we describe the epidemiology, pathology and screening guidelines for the management of patients with prostate and thyroid cancers; the evidence of overdiagnosis and overtreatment; and provide overviews of existing international active surveillance protocols.",
author = "Lowenstein, {Lisa Marie} and Basourakos, {Spyridon Panagiotis} and Williams, {Michelle Dianne} and Patricia Troncoso and Gregg, {Justin R.} and Timothy Thompson and Jeri Kim",
year = "2019",
month = "3",
day = "1",
doi = "10.1038/s41571-018-0116-x",
language = "English (US)",
volume = "16",
pages = "168--184",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Active surveillance for prostate and thyroid cancers

T2 - evolution in clinical paradigms and lessons learned

AU - Lowenstein, Lisa Marie

AU - Basourakos, Spyridon Panagiotis

AU - Williams, Michelle Dianne

AU - Troncoso, Patricia

AU - Gregg, Justin R.

AU - Thompson, Timothy

AU - Kim, Jeri

PY - 2019/3/1

Y1 - 2019/3/1

N2 - The adverse effects of overdiagnosis and overtreatment observed in men with clinically insignificant prostate cancers after the introduction of prostate-specific antigen-based screening are now being observed in those with thyroid cancer, owing to the introduction of new imaging technologies. Thus, the evolving paradigm of active surveillance in prostate and thyroid cancers might be valuable in informing the development of future active surveillance protocols. The lessons learned from active surveillance and their implications include the need to minimize the use of broad, population-based screening programmes that do not incorporate patient education and the need for individualized or shared decision-making, which can decrease the extent of overtreatment. Furthermore, from the experience in patients with prostate cancer, we have learned that consensus is required regarding the optimal selection of patients for active surveillance, using more-specific evidence-based methods for stratifying patients by risk. In this Review, we describe the epidemiology, pathology and screening guidelines for the management of patients with prostate and thyroid cancers; the evidence of overdiagnosis and overtreatment; and provide overviews of existing international active surveillance protocols.

AB - The adverse effects of overdiagnosis and overtreatment observed in men with clinically insignificant prostate cancers after the introduction of prostate-specific antigen-based screening are now being observed in those with thyroid cancer, owing to the introduction of new imaging technologies. Thus, the evolving paradigm of active surveillance in prostate and thyroid cancers might be valuable in informing the development of future active surveillance protocols. The lessons learned from active surveillance and their implications include the need to minimize the use of broad, population-based screening programmes that do not incorporate patient education and the need for individualized or shared decision-making, which can decrease the extent of overtreatment. Furthermore, from the experience in patients with prostate cancer, we have learned that consensus is required regarding the optimal selection of patients for active surveillance, using more-specific evidence-based methods for stratifying patients by risk. In this Review, we describe the epidemiology, pathology and screening guidelines for the management of patients with prostate and thyroid cancers; the evidence of overdiagnosis and overtreatment; and provide overviews of existing international active surveillance protocols.

UR - http://www.scopus.com/inward/record.url?scp=85056335646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056335646&partnerID=8YFLogxK

U2 - 10.1038/s41571-018-0116-x

DO - 10.1038/s41571-018-0116-x

M3 - Review article

VL - 16

SP - 168

EP - 184

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 3

ER -